Grown Rogue International (GRUSF) Return on Capital Employed (2011 - 2026)
Grown Rogue International (GRUSF) posted quarterly Return on Capital Employed of 1559049040420.34% for Q1 2026, down 49923005.18% quarter-over-quarter from 3122900.78% in Q4 2025.
Grown Rogue International (GRUSF) Return on Capital Employed (2011 - 2026) Analysis & Trends
Grown Rogue International's Return on Capital Employed history runs 15 years deep, the most recent figure standing at 1559049040420.34% for Q1 2026.
- In Q1 2026, Return on Capital Employed changed N/A year-over-year to 1559049040420.34%; the TTM figure through Mar 2026 stood at 1559049040420.34% (changed N/A YoY), while the FY2025 annual figure was 1.22%, down 165.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 1559049040420.34%, down from 3122900.78% in the prior quarter.
- The five-year high for Return on Capital Employed was 37.33% in Q1 2023, with the low at 1559049040420.34% in Q1 2026.
- The 4-year median for Return on Capital Employed is 16.95% (2024), against an average of 259842027202.12%.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 6.60% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 17.16% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 6.07% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 22.04% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -0.29% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 18.67% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 5.52% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Grown Rogue International | 109.32 Mn | 97.78 Mn | 5.37 Mn | 2,529,691.86% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3,175,541.49% |
| Mar 31, 2026 | -1,559,049,040,420.34% |
| Dec 31, 2025 | -3,122,900.78% |
| Sep 30, 2024 | 15.70% |
| Jun 30, 2024 | 18.20% |
| Mar 31, 2024 | 37.17% |
| Jan 31, 2023 | 37.33% |
| Apr 30, 2021 | -7.95% |
| Jan 31, 2021 | -1,435.34% |
| Oct 31, 2020 | -46.19% |
| Jul 31, 2020 | -112.95% |
| Jan 31, 2020 | 268.99% |
| Jan 31, 2019 | -162.65% |
| Oct 31, 2018 | 286.53% |
| Nov 30, 2017 | -147.76% |
| Aug 31, 2017 | 312.19% |
| May 31, 2017 | -1,020.01% |
| Feb 28, 2017 | -1,176.83% |
| Nov 30, 2016 | -1,495.24% |
| Aug 31, 2016 | 334.20% |